Center Laboratories, Inc. (TPEX:4123)

Center Laboratories Revenue

Center Laboratories had revenue of 432.06M TWD in the quarter ending June 30, 2026, with 14.09% growth. This brings the company's total for the last twelve months to 1.66B, up 3.63% year-over-year. In the year 2025, Center Laboratories had annual revenue of 1.52B, down -6.28%. That makes Center Laboratories the 27,865th largest company in the world by revenue and 1,314th in Taiwan.

• Revenue (ttm): 1.66B
• Revenue Growth: +3.63%
• P/S Ratio: 14.28
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 23.77B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Division 941.10M 61.1%
• Fenghua Sector/Department 576.17M 37.4%
• Shengzhi Venture 23.17M 1.5%

By Geography

Chart

• Taiwan 1.17B 77.2%
• China 322.43M 21.3%
• Others 23.37M 1.5%

Fiscal year ended Dec 31, 2025 See the full Center Laboratories breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.52B	-101.68M	-6.28%
Dec 31, 2024	1.62B	223.86M	16.06%
Dec 31, 2023	1.39B	626.29M	81.58%
Dec 31, 2022	767.72M	267.62M	53.51%
Dec 31, 2021	500.11M	-216.94M	-30.25%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 16, 2026

Data Sources Report a data error